KS

Kangjam Sagar Meitei

Active Director Director DIN 10138253
DIN 10138253 First appointment Apr 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Kangjam Sagar Meitei

Data last updated:

Kangjam Sagar Meitei is a Director at St. Marino Pharmaceuticals Private Limited (since 2023). The company operates in Healthcare.

DIN 10138253
Primary Designation Director
Industry Healthcare
First Appointment 28 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Apr 20232023Active

Board colleagues of Kangjam Sagar Meitei

NameDINCompanyDesignation
Island Kangjam10138252St. Marino Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
St. Marino Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kangjam Sagar Meitei

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kangjam Sagar Meitei

Kangjam Sagar Meitei currently holds 1 directorship: St. Marino Pharmaceuticals Private Limited (Director, since 28 Apr 2023).

Kangjam Sagar Meitei was first appointed on 28 Apr 2023 as Director at St. Marino Pharmaceuticals Private Limited.

The current boards of Kangjam Sagar Meitei's companies include Island Kangjam (St. Marino Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available